| + |
TBK1 | down-regulates quantity by destabilization
phosphorylation
|
PBXIP1 |
0.289 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-273811 |
Ser147 |
REEGRCSsSDDDTDV |
Homo sapiens |
HEK-293 Cell |
| pmid |
sentence |
| 24488098 |
MDM2-dependent HPIP degradation occurs in breast cancer cells on its phosphorylation by the estrogen-activated kinase TBK1. Phosphorylation of HPIP on serine 147 by TBK1 promotes E2-mediated GREB1 expression. |
|
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-273643 |
Ser147 |
REEGRCSsSDDDTDV |
Homo sapiens |
HEK-293 Cell |
| pmid |
sentence |
| 24488098 |
Phosphorylation of HPIP on serine 147 by TBK1 promotes E2-mediated GREB1 expression. Accordingly, we identified the microtubule-associated HPIP, a positive regulator of oncogenic AKT signaling, as a novel MDM2 substrate. MDM2-dependent HPIP degradation occurs in breast cancer cells on its phosphorylation by the estrogen-activated kinase TBK1. |
|
| Publications: |
2 |
Organism: |
Homo Sapiens |
| + |
IKBKE | down-regulates quantity by destabilization
phosphorylation
|
PBXIP1 |
0.2 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-276618 |
Ser147 |
REEGRCSsSDDDTDV |
Homo sapiens |
HEK-293 Cell |
| pmid |
sentence |
| 24488098 |
Accordingly, we identified the microtubule-associated HPIP, a positive regulator of oncogenic AKT signaling, as a novel MDM2 substrate. MDM2-dependent HPIP degradation occurs in breast cancer cells on its phosphorylation by the estrogen-activated kinase TBK1. |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
PBXIP1 | down-regulates activity
binding
|
PBX1 |
0.333 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-273666 |
|
|
Homo sapiens |
HEK-293 Cell |
| pmid |
sentence |
| 24488098 |
This protein that we have termed hematopoietic PBX-interacting protein (HPIP) is mainly localized in the cytosol and in small amounts in the nucleus. The region of PBX that interacts with HPIP includes both the homeodomain and immediate N-terminal flanking sequences. Strikingly, electrophoretic mobility shift assays revealed that HPIP inhibits the ability of PBX-HOX heterodimers to bind to target sequences. |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
MDM2 | down-regulates quantity by destabilization
polyubiquitination
|
PBXIP1 |
0.289 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-272850 |
|
|
Homo sapiens |
MCF-7 Cell |
| pmid |
sentence |
| 24488098 |
. Accordingly, we identified the microtubule-associated HPIP, a positive regulator of oncogenic AKT signaling, as a novel MDM2 substrate. MDM2-dependent HPIP degradation occurs in breast cancer cells on its phosphorylation by the estrogen-activated kinase TBK1. |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
PBXIP1 | down-regulates activity
binding
|
PBX2 |
0.268 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-273667 |
|
|
Homo sapiens |
HEK-293 Cell |
| pmid |
sentence |
| 24488098 |
This protein that we have termed hematopoietic PBX-interacting protein (HPIP) is mainly localized in the cytosol and in small amounts in the nucleus. The region of PBX that interacts with HPIP includes both the homeodomain and immediate N-terminal flanking sequences. Strikingly, electrophoretic mobility shift assays revealed that HPIP inhibits the ability of PBX-HOX heterodimers to bind to target sequences. |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |